Danaher Corp Stock Forecast for 2023 - 2025 - 2030
Updated on 03/23/2023
Danaher Corp Stock Forecast and Price Target
The average target price for Danaher Corp's stock set by renowned analysts in recent months is $304.50, representing a potential upside of approximately 23.41% from its last closing price if met by 2024. This estimation is based on a high estimate of $365.00 and a low estimate of $242.00. Although you may not be interested in DHR stock, you should still be aware of its competitors.
23.41% Upside
Danaher Corp Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Danaher Corp's Price has grown, moving from $135.25 to $299.88 – an increase of 121.72%. In the next year, analysts predict that Fair Value will jump to $334.15 – up 11.43% from the current level. Looking ahead to eight years, experts forecast that Fair Value will grow by 60.93%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific Inc | Outperform |
10
|
$554.66 | $618.99 | 11.78% |
| A Stock Forecast | Agilent Technologies | Outperform |
17
|
$131.13 | $162.50 | 26.97% |
| ILMN Stock Forecast | Illumina Inc | Outperform |
16
|
$216.92 | $254.08 | 15.02% |
| MTD Stock Forecast | Mettler-Toledo International I... | Hold |
13
|
$1.45k | $1.39k | -5.78% |
| WAT Stock Forecast | Waters Corp | Hold |
15
|
$298.13 | $336.44 | 14.04% |
Danaher Corp Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Danaher Corp's Revenue has grown, moving from $17.91B to $31.47B – an increase of 75.71%. In the next year, analysts predict that Revenue will jump to $32.27B – up 2.53% from the current level. Looking ahead to eight years, experts forecast that Revenue will grow by 25.61%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| PKI Stock Forecast | PerkinElmer | Outperform |
16
|
$123.74 | $159.83 | 31.32% |
| AVTR Stock Forecast | Avantor | Buy |
16
|
$21.02 | $0.00 | 114.08% |
| BIO Stock Forecast | Bio-Rad Laboratories | Buy |
16
|
$456.32 | $606.00 | 27.65% |
Danaher Corp Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Danaher Corp's Dividend per Share has seen an increase, rising from $0.68 to $1.08. This represents a growth of 58.82%. Analysts predict that Danaher Corp's Dividend per Share will increase in the upcoming year, reaching $1.12. This would represent an increase of 3.70%. Over the next eight years, experts predict that Danaher Corp's Dividend per Share will grow at a rate of 62.16%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| BRKR Stock Forecast | Bruker Corp | Outperform |
16
|
$74.87 | $72.11 | 0.17% |
| COHR Stock Forecast | Coherent | Hold |
12
|
$266.22 | $255.33 | 7.95% |
| PACB Stock Forecast | Pacific Biosciences of Califor... | Outperform |
9
|
$9.23 | $17.33 | 78.76% |
Danaher Corp Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last three years, Free Cash Flow for Danaher Corp has grown by 214317924.19%, going from $3.32B to $7107.00T. In the following year, 8 experts forecast Danaher Corp's Free Cash Flow will decrease by 100.00%, to $8.05B. In 2030, professionals predict that Danaher Corp's Free Cash Flow will decrease by 100.00%, to $10.50B.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| FLDM Stock Forecast | Fluidigm | - |
11
|
$20.32 | $12.00 | -91.29% |
| HBIO Stock Forecast | Harvard Bioscience | Buy |
14
|
$3.17 | $10.00 | 215.46% |
| EQTL Stock Forecast | Equitech International | - |
0
|
$2.00 | $0.00 | -100.00% |
Danaher Corp Net Income Forecast for 2023 - 2025 - 2030
Danaher Corp's Net Income has seen growth In the last three years, going from $3.01B to $7.21B – a gain of 139.64% In the next year, analysts believe that Net Income will reach $8.05B – an increase of 11.60%. For the next eight years, the forecast is forNet Income to grow by 40.91%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| OMRX Stock Forecast | Orthometrix | - |
0
|
$0.00 | $0.00 | 0.00% |
| LFPI Stock Forecast | LifePoint | - |
0
|
$0.00 | $0.00 | 0.00% |
| MDIT Stock Forecast | Medite Cancer Diagnostics | - |
0
|
$0.00 | $0.00 | 0.00% |
Danaher Corp EBITDA Forecast for 2023 - 2025 - 2030
Danaher Corp's EBITDA has grown in the last three years, jumping from $4.47B to $11.00B – an increase of 145.95%. In the next year, analysts predict that EBITDA will reach $11.18B – an increase of 1.71%. For the next eight years, the forecast is for EBITDA to grow by 24.57%.
Danaher Corp EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Danaher Corp's EBIT has increased by 148.92%, going from $3.28B to $8.17B. In the next year, analysts are expecting an increase in EBIT, predicting it will reach $8.73B – an increase of 6.86%. The Danaher Corp forecast is for EBIT to reach $11.08B or grow by 35.66%.
Danaher Corp EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Danaher Corp's EPS has grown, moving from $4.42 to $9.80 – an increase of 121.72%. In the next year, analysts predict that EPS will jump to $10.92 – up 11.43% from the current level. Looking ahead to eight years, experts forecast that EPS will grow by 60.93%.